Monday, June 4 , 2007

OncoLink at ASCO
OncoLink reporters provide in-depth coverage of scientific presentations from the 43rd Annual ASCO Meeting.


A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy (EORTC 08993-22993) A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy (EORTC 08993-22993) A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy (EORTC 08993-22993) A randomized, controlled, double-blind phase III study (AVOREN) of bevacizumab/interferon-a2a vs. placebo/interferon-a2a as first-line therapy in metastatic renal cell carcinoma A randomized, controlled, double-blind phase III study (AVOREN) of bevacizumab/interferon-a2a vs. placebo/interferon-a2a as first-line therapy in metastatic renal cell carcinoma Cigarette smoking during irinotecan therapy: Effects on pharmacokinetics and neutropenia Cigarette smoking during irinotecan therapy: Effects on pharmacokinetics and neutropenia Cigarette smoking during irinotecan therapy: Effects on pharmacokinetics and neutropenia Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT--Results of the randomized EORTC Phase III trial 22961 Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT--Results of the randomized EORTC Phase III trial 22961 Diurnal rhythms (DR) in gene expression in human oral mucosa: Implications for gender differences in toxicity, response and survival and optimal timing of targeted therapy (Rx) Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710 Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American Intergroup Protocol C9710 Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC) Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC) Satraplatin (S) demonstrates significant clinical benefits for the treatment of patients with HRPC: Results of a randomized phase III trial.

Keywords

Click on any of these terms for more related articles

Blogs

Roasted Vegetables and Farro
by Carolyn Vachani, MSN, RN, AOCN
September 30, 2013

Don't Assume You Understand
by Bob Riter
July 29, 2015

Related News

Demographic Variation in Early PET Scan Use for NSCLC

Jun 11, 2013

From 1998 to 2007, more scans for married, non-black, <80-year-old patients with lung cancer


A total of 64 percent of global asbestos use attributable to Asia from years 2001 to 2007

Jun 24, 2011

A total of 64 percent of global asbestos use attributable to Asia from years 2001 to 2007


Substantial decreases in overall U.S. cancer rates between 1990 and 2007

Jun 20, 2011

Substantial decreases in overall U.S. cancer rates between 1990 and 2007